In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
A director at Vanda Pharmaceuticals Inc sold/sold after exercising options 175,000 shares at 18.000USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's ...
Key Points: • The U.S. dollar has been unable to break to new highs and is vulnerable. We continue to believe that emerging markets and materials, especially gold are likely to benefit from a weakening U.S. dollar. This market resembles late 2015-early 2016 emerging market rout. • High yield corporate bonds are showing some stabilization as 10-year treasury yields moved to another low in face of the Fed tightening. • A number of Biotechs are indicating reversals and hitting multi-mont...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.